Literature DB >> 18329622

The variation in optical coherence tomography-measured macular thickness in diabetic eyes without clinical macular edema.

David J Browning1, Christina M Fraser, Bradley W Propst.   

Abstract

PURPOSE: To determine the variation in optical coherence tomography (OCT)-measured macular thickness in diabetic eyes without clinical edema and to investigate factors that might influence variation in macular thickness.
DESIGN: Retrospective, observational case series from a clinical practice.
METHODS: Review of clinical charts and longitudinal OCT measurements of a consecutive series of 56 eyes of 56 patients with diabetes but no clinical macular edema. Measured variables include OCT central subfield mean thickness (CSMT), total macular volume (TMV), and logarithm of the minimum angle of resolution (logMAR) visual acuity.
RESULTS: Over a median follow-up of 17 months, interquartile range (IQR) (9, 23), the median variation in CSMT was 18 microns, IQR (11, 31), and the median variation in TMV was 0.09 mm(3), IQR (0.06, 0.16). Variation in CSMT did not change significantly with increasing CSMT. Absolute, but not relative, variation in TMV increased with increasing baseline values (P = .0127 and P = .1538 for absolute variation and relative variation in TMV, respectively). The variation in CSMT and TMV did not vary with follow-up time and did not vary with age, gender, race, hypertension status, glycosylated hemoglobin, or retinopathy level.
CONCLUSIONS: Variation in CSMT and TMV in diabetic eyes without DME over intervals up to 17 months is no greater than OCT measurement variability in eyes without and with DME. A change in the OCT-measured macular thickness greater than 10% of the baseline thickness is likely to represent a true change in the macular thickness and not OCT measurement variability, diurnal variation, or variability occurring over longer time scales.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329622     DOI: 10.1016/j.ajo.2008.01.007

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Interpreting thickness changes in the diabetic macula: the problem of short-term variation in optical coherence tomography-measured macular thickening (an american ophthalmological society thesis).

Authors:  David J Browning
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

2.  Artifacts in optical coherence tomography.

Authors:  Jay Chhablani; Tandava Krishnan; Vaibhav Sethi; Igor Kozak
Journal:  Saudi J Ophthalmol       Date:  2014-04

3.  The change of macular thickness measured by optical coherence tomography in relation to glycemic control in diabetic patients.

Authors:  Sang Woong Moon; Hee-Young Kim; Seong-Woo Kim; Jaeryung Oh; Kuhl Huh; In Kyung Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-26       Impact factor: 3.117

4.  Optical coherence tomography imaging for diabetic retinopathy and macular edema.

Authors:  John C Buabbud; Motasem M Al-latayfeh; Jennifer K Sun
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

5.  Test-Retest Intervisit Variability of Functional and Structural Parameters in X-Linked Retinoschisis.

Authors:  Brett G Jeffrey; Catherine A Cukras; Susan Vitale; Amy Turriff; Kristin Bowles; Paul A Sieving
Journal:  Transl Vis Sci Technol       Date:  2014-10-03       Impact factor: 3.283

6.  SDOCT imaging to identify macular pathology in patients diagnosed with diabetic maculopathy by a digital photographic retinal screening programme.

Authors:  Sarah Mackenzie; Christian Schmermer; Amanda Charnley; Dawn Sim; Martin Dumskyj; Stephen Nussey; Catherine Egan
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

7.  Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration.

Authors:  Kakarla V Chalam; Sandeep Grover; Kumar Sambhav; Sankarathi Balaiya; Ravi K Murthy
Journal:  J Ophthalmol       Date:  2014-07-10       Impact factor: 1.909

8.  Central macular thickness in patients with type 2 diabetes mellitus without clinical retinopathy.

Authors:  Mehmet Demir; Ersin Oba; Burcu Dirim; Erhan Ozdal; Efe Can
Journal:  BMC Ophthalmol       Date:  2013-04-09       Impact factor: 2.209

9.  Cental Macular Thickness in Patients with Type 2 Diabetes Mellitus without Clinical Retinopathy.

Authors:  Mehmet Demir; Burcu Dirim; Zeynep Acar; Murat Yılmaz; Yekta Sendul
Journal:  J Ophthalmol       Date:  2013-04-03       Impact factor: 1.909

Review 10.  Spectral-domain optical coherence tomography for macular edema.

Authors:  Emmerson Badaró; Eduardo Novais; Larissa Maria Prodocimo; Juliana M Ferraz Sallum
Journal:  ScientificWorldJournal       Date:  2014-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.